查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年合成生物学全球市场
市场调查报告书
商品编码
1217643

2023-2030 年合成生物学全球市场

Global Synthetic Biology Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

工程原理在生物学中的应用是新兴的合成生物学跨学科领域的重点。 合成生物学旨在（重新）设计和製造自然界中不存在的生物系统和组件。 合成生物学使研究人员能够快速创建编目 DNA 序列并组装新的基因组。 合成生物学将 DNA 的化学合成与不断扩展的基因组学知识结合起来。 由于 DNA 合成的速度和成本，科学家们现在正在寻找改进的细菌染色体，用于製造改进的生物燃料、生物产品、可再生化学品、生物基特种化学品以及医疗保健行业。现在可以创造

市场动态

推动全球合成生物学市场的主要因素预计将是主要参与者推动市场的战略投资，以及诊断和技术改进和支持。 由于对蛋白质疗法、个性化医疗、合成药物和疫苗研究等的需求不断增长，预计该市场将会增长。

预计主要参与者的战略投资将推动市场增长。

目前，更多的资金分配给製药公司用于新药的研发。 补贴各种製药和生物技术公司的政府计划正在促进对营养补充剂和冥想的研究。

如果社会对合成生物学的看法发生变化，合成生物学产品的市场将会兴起。 因此，市场参与者正在通过收购和联合研究等活动投资于战略发展，以发展他们的公司并满足需求。 例如，SynBio Innovation Accelerator 于 2020 年 11 月由领先的合成生物学初创公司 Codexis, Inc. 和知名生命科学投资者 Casdin Capital 共同推出。 日本巨头住友化学在美国成立了一家名为 SynBio Hub 的新公司，旨在培育基于合成生物学的下一代业务。

合成生物学初创公司在 2020 年投资了 78 亿美元，到 2021 年达到 180 亿美元。 DNA Script 和 Arbor Biotechnologies 等公司分别筹集了约 2.15 亿美元和 1.672 亿美元。 大笔投资促进了资金在市场中的流动，并有助于扩大供应链上的业务。

市场扩张可能会因安全问题而受阻。

但是，有意或无意地将转基因生物释放到环境中会对人类和生态系统产生不利影响。 因此，预计市场扩张将受阻。

COVID-19 影响分析

由于 COVID-19 的爆发，合成生物学产品的使用在过去两年中有所扩大。 借助创建 COVID-19 检测试剂盒、治疗和免疫接种的新方法，许多领先的製药和生物技术公司以及合成生物学行业参与者正在全球范围内加紧研究工作。 根据欧洲议会的一项研究，合成生物学是新兴技术之一。 它可以应用于针对 COVID-19 传染病的措施。 美国国立卫生研究院正在考虑使用合成生物学来加快疫苗的研製。

合成生物学正在从一项基本的学术努力演变为一项已部分工业化的可靠战略。 在 COVID-19 大流行期间，合成生物学的生物医学潜力从未如此明显。 从研究的进步到疫苗、疗法和诊断学的快速发展，该领域正在为全球灾难做出重大贡献。 使许多合成生物学过程自动化，例如 DNA 和 RNA 的合成，对于推进这一重要领域至关重要。 为了利用合成生物学的发展势头并将其优势扩展到癌症、代谢病和遗传病等传染病以外的领域，有必要改进当前的自动化平台，并且仍然需要手动完成。步骤自动化应该继续下去。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 预计主要公司将进行战略投资以推动市场发展。
      • 通过诊断和技术改进提供支持
    • 约束因素
      • 安全问题很可能会阻碍市场扩张。
    • 机会
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 核心产品
    • 合成基因
    • 合成DNA
    • 合成细胞
    • 底盘生物
    • 其他
  • 可行的产品
    • 寡核甘酸合成
    • DNA合成

第八章技术

  • 基因合成
  • 基因组工程
  • 核甘酸测序
  • 生物信息学
  • 克隆
  • 定点诱变
  • 测量和建模
  • 微流体

第 9 章按应用

  • 医疗保健
  • 食品和农业
  • 化学品
  • 其他

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第12章公司简介

  • 阿米瑞斯公司
    • 公司概况
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Algenol Biofuels Inc.
  • Bayer AG
  • CBC Comprehensive Biomarker Center GmbH
  • Bristol-Myers Squibb
  • Biosearch Technologies Inc.
  • Gene Script Corporation
  • GeneWorks Pty Ltd.
  • DuPont Inc.
  • Thermo Fisher Scientific In.

第13章 DataM

简介目录
Product Code: DMBT2364

Market Overview

The global synthetic biology market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period (2023-2030).

The application of engineering principles to biology is the focus of the emerging interdisciplinary field of synthetic biology. It aspires to create biological systems and parts that do not already exist in the natural world through (re-)design and fabrication. With the help of synthetic biology, researchers can quickly produce cataloged DNA sequences and assemble them into new genomes. Synthetic biology combines the chemical synthesis of DNA with expanding genomics knowledge. Scientists are now able to create modified bacterial chromosomes that can be employed in manufacturing improved biofuels, bioproducts, renewable chemicals, and bio-based specialty chemicals, as well as in the healthcare industry, due to advancements in the speed and cost of DNA synthesis.

Market Dynamics

The major factors driving the global synthetic biology market the key companies are anticipated to make strategic investments to drive the market, improved diagnosis and techniques to support. The market is anticipated to rise in response to the rising demand for protein therapies, individualized medicine, and research into synthetic drugs and vaccines.

Key companies are anticipated to make strategic investments is expected to drive the market's growth.

More funding is now being allocated to pharmaceutical companies for research and development to find new medications. Government programs subsidizing various pharma and biotech companies have promoted research into dietary supplements and meditation.

The market for synthetic biology products rises as societal perceptions of synthetic biology change. As a result, major market players invest in strategic development through activities like acquisition, collaboration, etc., to grow their companies and meet demand. For instance, the SynBio Innovation Accelerator was introduced by premier synthetic biology start-up Codexis, Inc. and a renowned life science investor, Casdin Capital, in November 2020. One of the major players in Japan, Sumitomo Chemical, established SynBio Hub, a new company in the U.S., intending to foster the development of synthetic biology-based next-generation businesses.

In 2020, investments in start-ups in the synthetic biology industry totalled $7.8 billion, and in 2021, they reached $18.0 billion. Companies like DNA Script and Arbor Biotechnologies raised about 215 million and 167.2 million dollars, respectively. The significant investment promotes the flow of money through the market and aids in the expansion of businesses along the supply chain.

The market's expansion will likely be hampered by safety concerns.

However, the intentional or unintentional release of genetically modified organisms into the environment could have detrimental effects on the health of both people and the ecosystem. In consequence, it is anticipated that this will impede market expansion.

COVID-19 Impact Analysis

The use of synthetic biology products has expanded during the last two years due to the COVID-19 outbreak. By using novel methods for creating test kits, treatments, and vaccinations for COVID-19, many major pharmaceutical and bioTechnologies businesses and synthetic biology industry participants have intensified their research operations globally. Synthetic biology is one of the emerging technologies, according to a study from the European Parliament. It can be applied to the fight against COVID-19 infection. The National Institute of Health in the U.S. has also highlighted the use of synthetic biology to hasten the creation of vaccines.

Synthetic biology has evolved from a rudimentary academic endeavor to a solid, partially industrialized strategy. During the COVID-19 pandemic, the biomedical opportunities provided by synthetic biology have never been more apparent: from advancing research to enabling quicker development of vaccines, therapeutics, and diagnostics, this discipline has made great contributions during a worldwide catastrophe. Automating the many synthetic biology processes, such as DNA and RNA synthesis, has been crucial to developing this significant field. Building on the momentum of synthetic biology and extending its advantages to areas beyond infectious diseases, such as cancer, metabolic, and genetic disorders, companies would need to improve the present automation platforms and carry on with the automation of stages that are still done manually.

Segment Analysis

The healthcare segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)

The application segment is the highest market holder in the global synthetic biology market. The quick advancement of synthetic biology has driven the healthcare segment in terms of the various treatment techniques utilizing designed phages, artificial cells, and live bacteria.

For instance, it has made it possible for life technologies to create antigens and variants with high expression, quick outcomes, and capacity. Applications for synthetic biology range from the creation of drugs and vaccines to the production of products and diagnostic procedures.

Researchers use rational engineering methods to create unique, dynamic biosensing systems composed of a processor, sensor, and reporter. A growth in neurological diseases like multiple sclerosis is also fueling this market. For instance, starting in July 2022, synthetic biology specialists at the University of Toronto Engineering are creating personalized stem cells from patient tissues to treat ailments. These research initiatives are expected to support segment growth. Additionally, several initiatives performed by governments and other organizations are anticipated to benefit the market for research in this segment.

Geographical Analysis

North America holds the largest market share in the global synthetic biology market.

North America dominates the global Synthetic Biology market primarily due to its large population, excellent medical infrastructure, and high-income levels. Due to the expanding demand for bio-based products, rising investments in synthetic biology businesses, and rising R&D funding for synthetic biology, North America is predicted to have the greatest proportion of the global market for synthetic biology. as a result of greater government support, favorable laws, and increased investment in the development of synthetic biological products. In the first half of 2020, businesses in this industry, including Moderna Therapeutics, Sana BioTechnologies, Poseida Therapeutics, Apeel Sciences, and Greenlight Biosciences, raised more than $3 billion in financing.

Proteomics, genomic structure prediction, and drug development research are highly valued in the U.S., which is good for the synthetic biology sector. Additionally, certain for-profit businesses like the Gates and Melinda Foundation and government-funded research institutions like the National Institutes of Health (NIH) are promoting synthetic biology research and development, which could improve the chances for the nation's economic development. Additionally, growing funding from public and private organizations and R&D expenditures on drug development are significant growth factors anticipated to propel the market throughout the forecast period.

Competitive Landscape

The Synthetic Biology market is moderately competitive with local and global companies' presence Amyris Inc., Algenol Biofuels Inc., Bayer AG, CBC Comprehensive Biomarker Center GmbH, Bristol-Myers Squibb, Biosearch Technologies Inc., Gene Script Corporation, GeneWorks Pty Ltd., DuPont Inc., Thermo Fisher Scientific In and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in July 2021, addition to announcing the expansion of their research partnership, Codexis, Inc. and Kalsec, Inc. also signed a unique supply arrangement for a novel enzyme that will be used to create Kalsec's newest natural hop acid.

Thermo Fisher Scientific Inc.

Overview: In order to meet the demands of difficult analytical problems in research, diagnostics, and clinical laboratories, Thermo Fisher Scientific Inc. (Thermo Fisher) offers medical equipment, analytical instruments, reagents and consumables, software, and services. It provides answers for flow cytometry, synthetic biology, and cellular biology. The company offers a variety of goods, including as technologies for protein and molecular biology research, electron microscopy, mass spectrometry, and genetic sequencing. The business provides services to academic and research institutions, government agencies, pharmaceutical and biotech firms, clinical diagnostic laboratories, environmental, industrial quality, and process control sectors.

Product Portfolio:

Invitrogen GeneArt Gene Synthesis Services: Getting unique DNA constructions with 100% sequence fidelity is easy and affordable with GeneArt Custom Gene Synthesis. The company offers optimization using the patented GeneOptimizer algorithm, which uses a special multifactorial strategy that goes beyond codon optimization, to maximize the expression of synthetic genes.

The global Synthetic Biology market report would provide access to approx.: 45+ market data table, 40+ figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Key companies are anticipated to make strategic investments to drive the market.
      • 4.1.1.2. Improved diagnosis and techniques to support.
    • 4.1.2. Restraints:
      • 4.1.2.1. The market's expansion will likely be hampered by safety concerns.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Core Product
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
      • 7.2.2.1. Synthetic Genes
      • 7.2.2.2. Synthetic DNA
      • 7.2.2.3. Synthetic Cells
      • 7.2.2.4. Chassis Organisms
      • 7.2.2.5. Others
  • 7.3. Enabling Product
      • 7.3.1.1. Oligonucleotide Synthesis
      • 7.3.1.2. DNA Synthesis

8. By Technologies

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 8.1.2. Market Attractiveness Index, By Technologies
  • 8.2. Gene Synthesis
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 8.3. Genome Engineering
  • 8.4. Sequencing
  • 8.5. Bioinformatics
  • 8.6. Cloning
  • 8.7. Site-Directed Mutagenesis
  • 8.8. Measurement & Modeling
  • 8.9. Microfluidics

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Healthcare
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 9.3. Food & Agriculture
  • 9.4. Chemicals
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Amyris Inc
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Algenol Biofuels Inc.
  • 12.3. Bayer AG
  • 12.4. CBC Comprehensive Biomarker Center GmbH
  • 12.5. Bristol-Myers Squibb
  • 12.6. Biosearch Technologies Inc.
  • 12.7. Gene Script Corporation
  • 12.8. GeneWorks Pty Ltd.
  • 12.9. DuPont Inc.
  • 12.10. Thermo Fisher Scientific In.

LIST NOT EXHAUSTIVE

13. Global Synthetic Biology Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Application
  • 13.3. Contact Us